Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies
IntroductionFibroblast activation protein (FAP) is predominantly upregulated in various tumor microenvironments and scarcely expressed in normal tissues.MethodsWe analyzed FAP across 1216 tissue samples covering 23 tumor types and 70 subtypes.ResultsElevated FAP levels were notable in breast, pancre...
Main Authors: | Sebastian Dziadek, Anton Kraxner, Wei-Yi Cheng, Tai-Hsien Ou Yang, Mike Flores, Noah Theiss, Tsu-Shuen Tsao, Emilia Andersson, Suzana Vega Harring, Ann-Marie E. Bröske, Maurizio Ceppi, Volker Teichgräber, Jehad Charo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1352615/full |
Similar Items
-
Superficial CD34-positive fibroblastic tumor: A new entity; case report and review of literature
by: Neelam Sood, et al.
Published: (2017-01-01) -
Fibroblast growth factor 2 acts as an upstream regulator of inhibition of pulmonary fibroblast activation
by: Xiangqin Tian, et al.
Published: (2023-10-01) -
High expression of fibroblast‐activating protein is a prognostic marker in non‐small cell lung carcinoma
by: Naoki Yanagawa, et al.
Published: (2022-08-01) -
mRNA sequencing reveals the distinct gene expression and biological functions in cardiac fibroblasts regulated by recombinant fibroblast growth factor 2
by: Changye Sun, et al.
Published: (2023-07-01) -
Simultaneous Expression of CD70 and POSTN in Cancer-Associated Fibroblasts Predicts Worse Survival of Colorectal Cancer Patients
by: Masayuki Komura, et al.
Published: (2024-02-01)